Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar 13 multidose vial versus prefilled syringe in healthy Indian infants
2016-005134-29Phase 4
- Sponsor
- Pfizer
- Start
- Mar 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by Pfizer.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2016-005134-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005134-29.